Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI In Cancer Diagnostics Market, by End-user
1.4.2 Europe AI In Cancer Diagnostics Market, by Component
1.4.3 Europe AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 Europe AI In Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
Chapter 4. Europe AI In Cancer Diagnostics Market by End-user
4.1 Europe Hospital Market by Country
4.2 Europe Surgical Centers & Medical Institutes Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe AI In Cancer Diagnostics Market by Component
5.1 Europe Software Solutions Market by Country
5.2 Europe Hardware Market by Country
5.3 Europe Services Market by Country
Chapter 6. Europe AI In Cancer Diagnostics Market by Cancer Type
6.1 Europe Breast Cancer Market by Country
6.2 Europe Lung Cancer Market by Country
6.3 Europe Brain Tumor Market by Country
6.4 Europe Skin Cancer & Cervical Cancer Market by Country
6.5 Europe Prostate & Colorectal Cancer Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe AI In Cancer Diagnostics Market by Country
7.1 Germany AI In Cancer Diagnostics Market
7.1.1 Germany AI In Cancer Diagnostics Market by End-user
7.1.2 Germany AI In Cancer Diagnostics Market by Component
7.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
7.2 UK AI In Cancer Diagnostics Market
7.2.1 UK AI In Cancer Diagnostics Market by End-user
7.2.2 UK AI In Cancer Diagnostics Market by Component
7.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
7.3 France AI In Cancer Diagnostics Market
7.3.1 France AI In Cancer Diagnostics Market by End-user
7.3.2 France AI In Cancer Diagnostics Market by Component
7.3.3 France AI In Cancer Diagnostics Market by Cancer Type
7.4 Russia AI In Cancer Diagnostics Market
7.4.1 Russia AI In Cancer Diagnostics Market by End-user
7.4.2 Russia AI In Cancer Diagnostics Market by Component
7.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
7.5 Spain AI In Cancer Diagnostics Market
7.5.1 Spain AI In Cancer Diagnostics Market by End-user
7.5.2 Spain AI In Cancer Diagnostics Market by Component
7.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
7.6 Italy AI In Cancer Diagnostics Market
7.6.1 Italy AI In Cancer Diagnostics Market by End-user
7.6.2 Italy AI In Cancer Diagnostics Market by Component
7.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
7.7 Rest of Europe AI In Cancer Diagnostics Market
7.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
7.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
7.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 